{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:45:41Z","timestamp":1790214341846,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijcard.2022.12.056","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T11:42:33Z","timestamp":1672918953000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation"],"prefix":"10.1016","volume":"374","author":[{"given":"Mattia","family":"Zampieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Argir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Del Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Giovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Ferrantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter Dalma","family":"Palinkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5s4","key":"10.1016\/j.ijcard.2022.12.056_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.29.5S4.IV-3","article-title":"Idiopathic hypertrophic subaortic stenosis: I. a description of the disease based upon an analysis of 64 patients","volume":"29","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2022.12.056_bb0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.65.7.1388","article-title":"Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients","volume":"65","author":"Maron","year":"1982","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2022.12.056_bb0015","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/01.CIR.80.5.1489","article-title":"Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk","volume":"80","author":"McKenna","year":"1989","journal-title":"Circulation"},{"issue":"7844","key":"10.1016\/j.ijcard.2022.12.056_bb0020","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0140-6736(73)92730-X","article-title":"Prognosis and mortality of hypertrophic obstructive cardiomyopathy","volume":"302","author":"Hardarson","year":"1973","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijcard.2022.12.056_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2022.12.056_bb0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/hrt.2005.068577","article-title":"Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy","volume":"92","author":"Elliott","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2022.12.056_bb0035","article-title":"Effectiveness of the 2014 European Society of cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis","author":"O\u2019Mahony","year":"2018","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.ijcard.2022.12.056_bb0040","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2022.12.056_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","article-title":"Mortality among referral patients with hypertrophic cardiomyopathy vs the general European population","volume":"5","author":"Lorenzini","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2022.12.056_bb0050","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"39","key":"10.1016\/j.ijcard.2022.12.056_bb0055","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and Management of Hypertrophic Cardiomyopathy: the task force for the diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.12.056_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2021.04.023","article-title":"Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a tertiary referral Centre in Tuscany","volume":"335","author":"Zampieri","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.12.056_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"1","key":"10.1016\/j.ijcard.2022.12.056_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"4","key":"10.1016\/j.ijcard.2022.12.056_bb0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ. Heart Fail."},{"issue":"13","key":"10.1016\/j.ijcard.2022.12.056_bb0080","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2022.12.056_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2019.4268","article-title":"Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy","volume":"5","author":"Fumagalli","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"19","key":"10.1016\/j.ijcard.2022.12.056_bb0090","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse Prognosis of patients with hypertrophic cardiomyopathy who have Epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2022.12.056_bb0095","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors","volume":"113","author":"Spirito","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2022.12.056_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter\u2013defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2022.12.056_bb0105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.hrthm.2021.01.019","article-title":"Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: twenty years with the implantable cardioverter-defibrillator","volume":"18","author":"Maron","year":"2021","journal-title":"Heart Rhythm."},{"issue":"2","key":"10.1016\/j.ijcard.2022.12.056_bb0110","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jtcvs.2018.03.150","article-title":"Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: potential for refinement of current criteria","volume":"156","author":"Desai","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"38","key":"10.1016\/j.ijcard.2022.12.056_bb0115","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehab598","article-title":"Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy","volume":"42","author":"Nauffal","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2022.12.056_bb0120","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001843","article-title":"Clinical Spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy","volume":"8","author":"Pasqualucci","year":"2015","journal-title":"Circ. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2022.12.056_bb0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the heart failure Association of the European Society of cardiology","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2022.12.056_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2353\/jmoldx.2009.080082","article-title":"The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study","volume":"11","author":"Penicka","year":"2009","journal-title":"J. Mol. Diagn."},{"issue":"7","key":"10.1016\/j.ijcard.2022.12.056_bb0135","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.amjmed.2018.02.025","article-title":"Effect of spironolactone on myocardial fibrosis and other clinical variables in patients with hypertrophic cardiomyopathy","volume":"131","author":"Maron","year":"2018","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2022.12.056_bb0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/europace\/euw327","article-title":"Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy","volume":"20","author":"Killu","year":"2018","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.ijcard.2022.12.056_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-8587(14)70241-4","article-title":"Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial","volume":"3","author":"Axelsson","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6273","key":"10.1016\/j.ijcard.2022.12.056_bb0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ijcard.2022.12.056_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12265-009-9134-5","article-title":"Exercise in hypertrophic cardiomyopathy","volume":"2","author":"Day","year":"2009","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"25","key":"10.1016\/j.ijcard.2022.12.056_bb0160","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of Patients with hypertrophic cardiomyopathy: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"142","author":"Writing Committee Members","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2022.12.056_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12265-009-9137-2","article-title":"The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice","volume":"2","author":"Olivotto","year":"2009","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"36","key":"10.1016\/j.ijcard.2022.12.056_bb0170","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322019817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322019817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:59:38Z","timestamp":1759093178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322019817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"alternative-id":["S0167527322019817"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.12.056","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.12.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}